We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONT
8426
PUT
Onterris Inc
ONT
$580M
$402K ﹤0.01%
13,000
-1,500
-10% -$42.6K
URGN icon
8427
PUT
UroGen Pharma
URGN
$2.29B
$402K ﹤0.01%
+22,300
New +$467K
ABTC
8428
CALL
American Bitcoin Corp
ABTC
$471M
$402K ﹤0.01%
+4
New +$429K
EQNR icon
8429
PUT
Equinor
EQNR
$92.4B
$401K ﹤0.01%
24,400
+3,100
+15% +$46.9K
LNTH icon
8430
PUT
Lantheus
LNTH
$6.59B
$401K ﹤0.01%
29,758
+4,058
+16% +$53.1K
PHAT icon
8431
Phathom Pharmaceuticals
PHAT
$692M
$401K ﹤0.01%
12,076
+5,360
+80% +$217K
VCYT icon
8432
CALL
Veracyte
VCYT
$3.8B
$401K ﹤0.01%
+8,200
New +$380K
WMS icon
8433
PUT
Advanced Drainage Systems
WMS
$10.9B
$401K ﹤0.01%
4,800
-4,000
-45% -$283K
GPRK icon
8434
GeoPark
GPRK
$612M
$400K ﹤0.01%
30,754
-2,900
-9% -$27.4K
PGRE
8435
PUT
DELISTED
Paramount Group
PGRE
$400K ﹤0.01%
44,200
-1,400
-3% -$11.3K
QFIN icon
8436
Qfin Holdings
QFIN
$1.61B
$400K ﹤0.01%
33,925
-30,935
-48% -$370K
WERN icon
8437
PUT
Werner Enterprises
WERN
$2.25B
$400K ﹤0.01%
10,200
-7,700
-43% -$313K
YCBD icon
8438
PUT
cbdMD
YCBD
$5.93M
$400K ﹤0.01%
377
+208
+123% +$189K
CORR
8439
CALL
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$400K ﹤0.01%
58,400
+45,600
+356% +$276K
DBJP icon
8440
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$705M
$399K ﹤0.01%
8,707
-2,383
-21% -$102K
FDTS icon
8441
First Trust Developed Markets ex-US Small Cap AlphaDEX Fund
FDTS
$13.7M
$399K ﹤0.01%
9,223
+615
+7% +$23.9K
FHI icon
8442
CALL
Federated Hermes
FHI
$4.72B
$399K ﹤0.01%
13,800
-6,100
-31% -$162K
HCSG icon
8443
CALL
Healthcare Services Group
HCSG
$1.53B
$399K ﹤0.01%
14,200
+3,700
+35% +$89.5K
JNCE
8444
CALL
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$398K ﹤0.01%
56,900
+900
+2% +$7K
AIMC
8445
DELISTED
Altra Industrial Motion Corp
AIMC
$398K ﹤0.01%
7,186
-16,637
-70% -$820K
OMP
8446
CALL
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
$398K ﹤0.01%
+33,900
New +$334K
USLB
8447
DELISTED
Invesco Russell 1000 Low Beta Equal Weight ETF
USLB
$398K ﹤0.01%
11,312
-11,530
-50% -$386K
WLL
8448
PUT
DELISTED
Whiting Petroleum Corporation
WLL
$398K ﹤0.01%
+15,933
New +$320K
IDYA icon
8449
IDEAYA Biosciences
IDYA
$3.56B
$397K ﹤0.01%
+28,336
New +$384K
IYM icon
8450
CALL
iShares US Basic Materials ETF
IYM
$1.25B
$397K ﹤0.01%
+3,500
New +$373K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.